Izotropic Corporation
IZO
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -56.49% | -46.19% | -73.09% | -60.18% | -2.27% |
| Depreciation & Amortization | 1.24% | 32.49% | 90.83% | 247.20% | 520.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -53.71% | -50.77% | -69.44% | -56.99% | -19.62% |
| Operating Income | 53.71% | 50.77% | 69.44% | 56.99% | 19.62% |
| Income Before Tax | 58.38% | 54.69% | 72.74% | 54.86% | 18.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 58.38% | 54.69% | 72.74% | 54.86% | 18.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.38% | 54.69% | 72.74% | 54.86% | 18.61% |
| EBIT | 53.71% | 50.77% | 69.44% | 56.99% | 19.62% |
| EBITDA | 53.66% | 51.06% | 70.10% | 57.55% | 20.34% |
| EPS Basic | 61.18% | 57.72% | 74.05% | 58.41% | 28.04% |
| Normalized Basic EPS | 52.36% | 50.00% | 67.17% | 58.36% | 28.04% |
| EPS Diluted | 61.18% | 57.72% | 74.05% | 58.41% | 28.04% |
| Normalized Diluted EPS | 52.36% | 50.00% | 67.17% | 58.36% | 28.04% |
| Average Basic Shares Outstanding | 6.84% | 7.18% | 7.34% | 9.39% | 12.85% |
| Average Diluted Shares Outstanding | 6.84% | 7.18% | 7.34% | 9.39% | 12.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
